Tirzepatide once weekly for obesity treatment (SURMOUNT-1 trial)
study005
10.1056/NEJMoa2206038
New England Journal of Medicine
randomized clinical trial
Dual GIP/GLP-1 agonist tirzepatide evaluated for weight management.
Significant reductions in body weight observed across treatment arms.
tirzepatide
fat-loss|metabolism
advanced-metabolic-stack
semaglutide-vs-tirzepatide
published